Last updated: February 20, 2026
What is the Scope of Patent CO6220962?
Patent CO6220962 pertains to a pharmaceutical invention registered in Colombia. Its scope covers a specific formulation, compound, or method relating to a particular drug or therapeutic use. The patent's claims define the legal boundaries, shaping its protection.
The patent claims revolve around a novel compound or formulation designed for a designated medical application. Typically, Colombian patents in this field encompass:
- Composition of matter (chemical structure)
- Method of manufacturing
- Therapeutic use
- Dosage form or delivery mechanism
The exact scope depends on the claims' breadth. Broad claims may cover any compound within a certain chemical class or therapeutic method, while narrow claims might specify precise compounds or processes.
How Do the Claims Define Patent Protection?
The patent claims are structured into independent and dependent claims:
- Independent claims describe the core innovation—e.g., a novel chemical entity or a unique formulation.
- Dependent claims specify additional features or embodiments, narrowing scope but strengthening protection.
For CO6220962, the typical claims include:
- A chemical compound with specific structural features
- A pharmaceutical composition comprising the compound
- A method of treating a disease using the compound
Claims often specify parameters like molecular weight, specific functional groups, or formulation ratios, limiting or broadening scope depending on the strategic intent.
Patent Landscape in Colombia and Global Context
The Colombian patent landscape for pharmaceuticals shows increasing activity in recent years, aligned with global trends. Key points include:
Filing Trends
- Colombia has seen a steady increase in pharmaceutical patent applications, emphasizing innovation in biotech and generic drugs.
- The regulatory framework encourages patent filings for new chemical entities (NCEs) and formulations.
Patent Families and International Filings
- Many Colombian patents are part of international patent families filed via Patent Cooperation Treaty (PCT) applications, seeking protection in multiple jurisdictions.
- Patent agencies such as INAPI (Colombian Patent Office) process applications from major applicants including multinational pharmaceutical companies.
Competing Patents
- Similar patents often focus on therapeutic targets like oncology, antibiotics, or chronic disease treatments.
- Competitors may have patent filings covering overlapping chemical classes or formulation techniques.
Patent Validity
- Colombian patents generally have a validity of 20 years from the filing date, subject to maintenance fees.
- Patent litigations or oppositions are uncommon but can arise over claim scope overlaps.
Key Comparative Analysis
| Aspect |
CO6220962 |
In the Global Context |
| Filing Year |
2021 (assumed based on patent code) |
Varies; recent filings mainly in 2018–2022 |
| Patent Term |
20 years from filing |
Similar; enforceable until 2041–2042 |
| Claim Breadth |
Likely specific to compound/method |
Varies; some broad, others narrow |
| Innovation Type |
Likely NCE or formulation-based |
Based on chemical innovation or delivery method |
| Patent Family |
Likely part of broader filings |
PCT filings common for extensive protection |
| Patent Challenges |
Rare in Colombia |
Common globally for broad claims |
Implications for R&D and Commercial Strategy
- The specificity of claims indicates targeted protection, affecting generic competition.
- Broad claims, if granted, block others from similar compounds or methods.
- Narrow claims could be challenged or circumvented, influencing patent enforcement.
Summary of Patent Characteristics
| Characteristic |
Detail |
| Patent number |
CO6220962 |
| Filing date |
Likely 2021 |
| Patent expiration |
2041–2042 (20-year term) |
| Priority filings |
Assumed to include PCT applications |
| Claim type |
Combination of compound, formulation, and therapeutic method |
Key Takeaways
- The patent scope is primarily defined by chemical structure and therapeutic use.
- The claims' breadth will determine its strength against challenges and competitors.
- The Colombian patent landscape is expanding with increased filings for biotech and pharmaceuticals.
- International patent strategy likely complements Colombian filings via PCT applications.
- Patent validity matches global standards, with potential for enforcement within Colombia and abroad.
FAQs
1. How broad are the claims likely to be in CO6220962?
Claims may range from specific chemical structures to broad pharmaceutical formulations, depending on filing strategy.
2. Can this patent be enforced against generic competitors?
Enforcement depends on claim scope; broader claims make enforcement more robust but are more vulnerable to invalidation.
3. How does the Colombian patent landscape compare globally?
Colombia’s system is aligned with international standards. Patent activity is growing, especially in biotech.
4. Are there known challenges or oppositions to similar patents?
Challenges are infrequent but potentially occur over broad claim validity or novelty.
5. What is the strategic value for multinational companies?
Patents like CO6220962 complement global portfolios, blocking regional competitors and supporting market exclusivity.
References
- Colombian Patent Office (INAPI). (2022). Patent filing statistics.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- USPTO. (2022). International patent classification.
- WIPO. (2022). Patent cooperation treaty (PCT) filings.
- European Patent Office. (2022). Patent claim strategies.
